The growing use of GLP-1 weight-loss drugs in the UK has already affected consumption habits – and the green light for the sale of a pill form of the medication will likely add momentum to the changes seen across food and drink categories.
Looking at the early evidence in the US, the arrival of GLP‑1 weight‑loss drugs in pill form in the UK looks set to increase uptake, which should focus minds across food and drinks manufacturers.
The growing use of GLP-1 weight-loss drugs in the UK has already affected consumption habits – and the green light for the sale of a pill form of the medication will likely add momentum to the changes seen across food and drink categories.